Sign in
PTPI Stock Price, Chart, Stats & News
Petros Pharmaceuticals, Inc.
Save
Petros Pharmaceuticals, Inc. (PTPI) does not currently pay a dividend.
271,182
Market cap
–
Current P/E
–
Forward P/E
PTPI chart
1M
3M
1Y
5Y
Loading chart...
About
Health care
Sector
Drug Manufacturers - Specialty & Generic
Industry
Petros Pharmaceuticals, Inc. is a pharmaceutical company dedicated to male health solutions. Their activities include both the commercialization and ongoing development of Stendra, a prescription PDE-5 inhibitor specifically designed for treating erectile dysfunction (ED). Furthermore, Petros is advancing H100, a proprietary topical formulation currently in development as a potential treatment for acute Peyronie's disease.
Similar securities
Based on sector and market capitalization
Report issue